Dream content in Parkinson’s Disease
Objective: The aim of this observational study is to perform an analysis of dream characteristics in a large sample of Parkinson's Disease (PD) patients and…Relationship between neuropsychological functioning and subjective measures of sleep quality in Parkinson Disease
Objective: To analyze the relationship between subjectively reported sleep alterations and cognitive functions in a large series of advanced Parkinson Disease (PD) patients evaluated with…Olfactory dysfunction in patient of Scans Without Evidence of Dopaminergic Deficit with parkinsonian bradykinesia
Objective: To investigate the differences of olfactory dysfunction in patients within SWEDDs Background: The concept of SWEDD(scans without evidence of dopaminergic deficit) originates from the clinical…Clinical correlates of severe somnolence in Parkinson’s disease: results from an international naturalistic non-motor symptoms cohort
Objective: To compare patients with mild and severe daytime somnolence using cut-off values from item 15 of the Parkinson’s disease (PD) sleep scale (PDSS). Background:…Parkinson’s disease and progressive dysphagia – consider myasthenia gravis
Objective: We report on three consecutive patients with Parkinson’s disease, in whom myasthenia gravis turned out responsible for progressive dysphagia. Background: Swallowing dysfunction is common…The utility of post-void residual volume versus sphincter electromyography to distinguish between multiple system atrophy and Parkinson’s disease
Objective: To determine the ability of sphincter electromyography (EMG) and post-void residual urine volume (PVR) during a free-flow study and a pressure-flow study (PFS) for…Gait characteristics in Atypical Parkinsonism
Objective: We investigated gait characteristics of progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), with the aim to elucidate relatively specific disease differences in…The environmental and genetic risk factors in multiple system atrophy in a Taiwanese population
Objective: The etiology of MSA remains uncertain. Cholesterol and its metabolism derangements, α-Synuclein and CoQ2 genetic polymorphism have been disclosed to be associated with the…Rolipram, a PDE-IV inhibitor protects against experimental Parkinsonism in mice
Objective: Rolipram, a specific inhibitor of the phosphodiesterase IV (PDE IV), has recently been shown to exert neuroprotective effects in an Alzheimer transgenic mouse model…Gait impairment and cognitive changes in a case of thalamic dementia and motor neuron disease.
Objective: To describe a case of a 54-year-old woman diagnosed with atypical corticobasal syndrome (CBS). Neuropathological studies revealed that she had thalamic dementia with motor…
- 1
- 2
- 3
- …
- 155
- Next Page »